BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

Go back to BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
(AMEX: BMKDF) Delayed: 0.40 --0 (-0%)
Previous Close $0.40    52 Week High $0.14 
Open $0.40    52 Week Low $0.04 
Day High $0.40    P/E N/A 
Day Low $0.40    EPS $0.00 
Volume 271,388